$DYCQ
DT Cloud Acquisition Corp

2024 Q3 Form 10-Q Financial Statement

#000149315224029597 Filed on July 30, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $78.47K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $157.6K $78.47K $257.00
YoY Change 2896.39% 30433.07%
Operating Profit
YoY Change
Interest Expense $907.3K
YoY Change
% of Operating Profit
Other Income/Expense, Net $917.9K $907.3K
YoY Change
Pretax Income $828.9K
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $760.3K $828.9K -$257.00
YoY Change -14553.65% -322615.95%
Net Earnings / Revenue
Basic Earnings Per Share $0.08 $0.09 $0.00
Diluted Earnings Per Share $0.08 $0.09 $0.00
COMMON SHARES
Basic Shares Outstanding 8.963M shares 8.963M shares 1.500M shares
Diluted Shares Outstanding 2.063M shares 2.063M shares 1.500M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $314.4K
YoY Change
Cash & Equivalents $167.5K $314.4K
Short-Term Investments
Other Short-Term Assets $53.06K
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $205.5K $367.5K
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $70.60M
YoY Change
Other Assets $0.00
YoY Change
Total Long-Term Assets $71.52M $70.60M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $205.5K $367.5K
Total Long-Term Assets $71.52M $70.60M
Total Assets $71.72M $70.97M
YoY Change 75396.75%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses $68.61K $103.0K
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $138.6K $143.0K
YoY Change -11.48%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $1.725M
YoY Change
Total Long-Term Liabilities $1.725M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $138.6K $143.0K
Total Long-Term Liabilities $1.725M
Total Liabilities $1.864M $1.868M
YoY Change 1090.2%
SHAREHOLDERS EQUITY
Retained Earnings -$1.658M -$1.501M
YoY Change
Common Stock $206.00 $206.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$1.658M -$1.501M -$56.58K
YoY Change
Total Liabilities & Shareholders Equity $71.72M $70.97M
YoY Change 75396.75%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income $760.3K $828.9K -$257.00
YoY Change -14553.65% -322615.95%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$25.43K
YoY Change
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities $0.00
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities -25.43K
Cash From Investing Activities 0.000
Cash From Financing Activities 0.000
Net Change In Cash -25.43K
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$25.43K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 DYCQ Stock Issued During Period Value Representative Share
StockIssuedDuringPeriodValueRepresentativeShare
usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
usd
us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
usd
CY2023Q2 us-gaap Cash
Cash
usd
CY2024Q2 us-gaap Escrow Deposit
EscrowDeposit
usd
CY2023Q2 us-gaap Escrow Deposit
EscrowDeposit
usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
usd
DYCQ Issuance Of Representative Share
IssuanceOfRepresentativeShare
usd
DYCQ Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
usd
DYCQ Allocation Of Offering Costs To Common Stock Subject To Possible Redemption
AllocationOfOfferingCostsToCommonStockSubjectToPossibleRedemption
usd
DYCQ Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
usd
DYCQ Subsequent Remeasurement Of Common Stock Subject To Redemptions
SubsequentRemeasurementOfCommonStockSubjectToRedemptions
usd
DYCQ Accrued Underwriting Compensation
AccruedUnderwritingCompensation
usd
CY2023Q4 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.13
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.13
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-143597 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
66023894 usd
CY2024Q1 DYCQ Stock Issued During Period Value Private Placement
StockIssuedDuringPeriodValuePrivatePlacement
2345000 usd
CY2024Q1 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
-68014286 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Other
AdjustmentsToAdditionalPaidInCapitalOther
2933590 usd
CY2024Q1 DYCQ Adjustments To Additional Paid In Capital Redemption Value
AdjustmentsToAdditionalPaidInCapitalRedemptionValue
-4264304 usd
CY2024Q1 DYCQ Subsequent Remeasurement Of Common Stock Subject To Redemption
SubsequentRemeasurementOfCommonStockSubjectToRedemption
-346250 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
43875 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1422078 usd
CY2024Q2 DYCQ Subsequent Remeasurement Of Common Stock Subject To Redemption
SubsequentRemeasurementOfCommonStockSubjectToRedemption
-907328 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
828866 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-1500540 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
-56326 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-257 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-257 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
-56583 usd
us-gaap Net Income Loss
NetIncomeLoss
872741 usd
us-gaap Net Income Loss
NetIncomeLoss
-257 usd
us-gaap Investment Income Dividend
InvestmentIncomeDividend
1253578 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
44612 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-177614 usd
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
257 usd
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
78753 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-524310 usd
us-gaap Payments For Proceeds From Other Deposits
PaymentsForProceedsFromOtherDeposits
69345000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-69345000 usd
us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
490000 usd
us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
67833894 usd
us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
2345000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
69688894 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-180416 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
494818 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
314402 usd
CY2024Q2 us-gaap Cash
Cash
314402 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
314402 usd
DYCQ Issuance Of Representative Share
IssuanceOfRepresentativeShare
10 usd
DYCQ Initial Classification Of Common Stock Subject To Possible Redemption
InitialClassificationOfCommonStockSubjectToPossibleRedemption
68014286 usd
DYCQ Allocation Of Offering Costs To Common Stock Subject To Possible Redemption
AllocationOfOfferingCostsToCommonStockSubjectToPossibleRedemption
2933590 usd
DYCQ Accretion Of Carrying Value To Redemption Value
AccretionOfCarryingValueToRedemptionValue
4264304 usd
DYCQ Subsequent Remeasurement Of Common Stock Subject To Redemptions
SubsequentRemeasurementOfCommonStockSubjectToRedemptions
1253578 usd
DYCQ Accrued Underwriting Compensation
AccruedUnderwritingCompensation
1725000 usd
CY2024Q2 DYCQ Percent Of Obligation To Redeem Public Shares
PercentOfObligationToRedeemPublicShares
1 pure
CY2024Q2 DYCQ Percentage Of Redemption Rights
PercentageOfRedemptionRights
0.15 pure
CY2024Q2 DYCQ Percent Of Obligation To Redeem Public Shares
PercentOfObligationToRedeemPublicShares
1 pure
CY2024Q2 us-gaap Deposits
Deposits
207000 usd
CY2024Q2 DYCQ Percent Of Obligation To Redeem Public Shares
PercentOfObligationToRedeemPublicShares
1 pure
CY2024Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.05
CY2024Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
10.05
CY2024Q2 DYCQ Percent Of Obligation To Redeem Public Shares
PercentOfObligationToRedeemPublicShares
1 pure
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_841_eus-gaap--UseOfEstimates_zKL0pzt8ylv3" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_866_zzbX8gUcRbf7">Use of estimates</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited financial statement in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statement, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q2 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
70598578 usd
CY2024Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
6900000 shares
CY2024Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
6900000 shares
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
us-gaap Net Income Loss
NetIncomeLoss
872741 usd
us-gaap Net Income Loss
NetIncomeLoss
-257 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
828866 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-257 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_844_eus-gaap--ConcentrationRiskCreditRisk_zPK9TOA8yQQ7" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_869_z6kggMXnYl58">Concentration of credit risk</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of a cash account in a financial institution. The Company has not experienced losses on this account and management believes the Company is not exposed to significant risks on such account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q3 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1725000 shares
CY2022Q3 DYCQ Percentage Of Issued And Outstanding Shares After Initial Public Offering Collectively Held By Initial Stockholders
PercentageOfIssuedAndOutstandingSharesAfterInitialPublicOfferingCollectivelyHeldByInitialStockholders
0.20 pure
CY2022Q3 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
25000 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
40000 usd
CY2023 us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
490000 usd
CY2024Q2 DYCQ Unpaid Services Fee
UnpaidServicesFee
40000 usd
CY2023Q4 DYCQ Unpaid Services Fee
UnpaidServicesFee
0 usd
DYCQ Incurred Fees
IncurredFees
40000 usd
DYCQ Incurred Fees
IncurredFees
0 usd
CY2024Q2 DYCQ Incurred Fees
IncurredFees
30000 usd
CY2023Q2 DYCQ Incurred Fees
IncurredFees
0 usd
CY2024Q2 DYCQ Working Capital Loans
WorkingCapitalLoans
0 usd
CY2023Q4 DYCQ Working Capital Loans
WorkingCapitalLoans
0 usd
CY2024Q2 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
6900000 shares
CY2024Q2 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
6900000 shares
CY2023Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0 shares
CY2023Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0 shares
us-gaap Common Stock Voting Rights
CommonStockVotingRights
Each holder of a right will receive one-seventh (1/7) ordinary share upon consummation of a Business Combination, even if the holder of such right redeemed all shares held by it in connection with a Business Combination. No fractional shares will be issued upon exchange of the rights.

Files In Submission

Name View Source Status
0001493152-24-029597-index-headers.html Edgar Link pending
0001493152-24-029597-index.html Edgar Link pending
0001493152-24-029597.txt Edgar Link pending
0001493152-24-029597-xbrl.zip Edgar Link pending
dycq-20240630.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
dycq-20240630_cal.xml Edgar Link unprocessable
dycq-20240630_def.xml Edgar Link unprocessable
dycq-20240630_pre.xml Edgar Link unprocessable
dycq-20240630_lab.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed